1. FRI0035 Prediction of TNF Inhibitor Response in Rheumatoid Arthritis Patients Using Single Cell Network Profiling of Intracellular Immune Signaling. (10th June 2014) Authors: Ptacek, J.; Hawtin, R.; Louie, B.; Evensen, E.; Cordeiro, J.; Mittleman, B.; Atallah, M.; Cesano, A.; Cavet, G.; Bingham, C.O.; Cofield, S.S.; Curtis, J.R.; Danila, M.I.; Furie, R.; Genovese, M.C.; Levesque, M.C.; Moreland, L.W.; Nigrovic, P.A.; O'Dell, J.R.; Robinson, W.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0181 Changing Use of Methotrexate (MTX) and Biologics in The Treatment of Rheumatoid Arthritis (RA) in The United States (US): Results of A Comprehensive Pharmaceutical Claims Analysis. (15th July 2016) Authors: O'Dell, J.R.; Cohen, S.; Thorne, C.; Mikuls, T.R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0202 Omeract Method of Combined Reporting of Benefit and Harm Applied to the TEAR Trial. (10th June 2014) Authors: Boers, M.; Singh, J.A.; Cofield, S.S.; Bridges, S.L.; Moreland, L.W.; O'Dell, J.R.; Curtis, J.R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗